Szalai Bence, Veres Dániel V
Turbine Ltd., Budapest, Hungary.
Department of Molecular Biology, Semmelweis University, Budapest, Hungary.
Front Syst Biol. 2023 Feb 9;3:1126044. doi: 10.3389/fsysb.2023.1126044. eCollection 2023.
High dimensional characterization of drug targets, compound effects and disease phenotypes are crucial for increased efficiency of drug discovery. High-throughput gene expression measurements are one of the most frequently used data acquisition methods for such a systems level analysis of biological phenotypes. RNA sequencing allows genome wide quantification of transcript abundances, recently even on the level of single cells. However, the correct, mechanistic interpretation of transcriptomic measurements is complicated by the fact that gene expression changes can be both the cause and the consequence of altered phenotype. Perturbation gene expression profiles, where gene expression is measured after a genetic or chemical perturbation, can help to overcome these problems by directly connecting the causal perturbations to their gene expression consequences. In this Review, we discuss the main large scale perturbation gene expression profile datasets, and their application in the drug discovery process, covering mechanisms of action identification, drug repurposing, pathway activity analysis and quantitative modelling.
药物靶点、化合物效应和疾病表型的高维特征对于提高药物发现的效率至关重要。高通量基因表达测量是用于生物表型系统水平分析的最常用数据采集方法之一。RNA测序可实现全基因组转录本丰度的定量,最近甚至能在单细胞水平上进行。然而,由于基因表达变化既可能是表型改变的原因,也可能是其结果,这一事实使得对转录组测量进行正确的、基于机制的解释变得复杂。扰动基因表达谱,即在遗传或化学扰动后测量基因表达,通过直接将因果扰动与其基因表达后果联系起来,有助于克服这些问题。在本综述中,我们讨论了主要的大规模扰动基因表达谱数据集及其在药物发现过程中的应用,包括作用机制识别、药物再利用、通路活性分析和定量建模。